InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,157.46
(
0.58%
)
US TECH 100
17,513.20
(
0.54%
)
Dow Jones
38,787.39
(
0.29%
)
Brent Oil
83.46
(
0.40%
)
Bitcoin
63,952.86
(
-0.07%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

livinginsv

Send PM Follow Ignore
Followers 16
Posts 1354
Boards Moderated 0
Alias Born 05/11/2014

livinginsv

Re: guardiangel post# 29432

Monday, 06/29/2015 3:37:24 PM

Monday, June 29, 2015 3:37:24 PM

Post# of 30046
provista's method . . .

Methods: We have conducted two independent, multi-center, prospective clinical trials to establish the clinical validity of a breast cancer biomarker assay that uses a combination of Serum Protein Biomarkers (SPB), Tumor-Associated Autoantibodies (TAAb) with patient specific data to differentiate patients with benign breast disease from those with invasive breast cancer (IBC)

no DR-70 here either . . . and no presentation at ASCO, just a paper included in the ASCO docs . . . not good . . .

JT, how can ADI be a subsidiary of a non-existent corporation? . . .

i'm trying to pick the pocket of the big guys, while they're too busy robbing the bank to notice . . . long only . . .

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up